Retamed (10) vials 10mg-80mg

Retatrutide — New Zealand (10) vials.

Retatrutide is a synthetic peptide commonly studied in scientific and laboratory research involving metabolic signaling, glucose regulation, energy balance, and endocrine pathways. It is a triple receptor agonist targeting the GIP, GLP-1, and glucagon receptors, making it of interest in metabolic and receptor-signaling research.

Designed for controlled research environments, Retatrutide is supplied for analytical and experimental applications.

Key Features

• Synthetic research peptide

• Triple GIP, GLP-1, and glucagon receptor agonist

• Suitable for laboratory and analytical research

• Commonly studied in metabolic and endocrine research

• Relevant to glucose, energy-balance, and incretin-signaling pathways

• Clearly labeled for research purposes

Important: This product is intended strictly for research purposes only. It is not intended for human or veterinary use, consumption, diagnosis, treatment, or prevention of any disease.